Pages that link to "Item:Q2219776"

The following pages link to Cancer immunotherapy, mathematical modeling and optimal control (Q2219776):

Displaying 50 items.

• A modified numerical method for bifurcations of fixed points of ODE systems with periodically pulsed inputs (Q273321) (← links)
• A mathematical model for the dynamics of cancer hepatocytes under therapeutic actions (Q285210) (← links)
• Mathematical and numerical analysis of a mathematical model of mixed immunotherapy and chemotherapy of cancer (Q316874) (← links)
• Improved relaxations for the parametric solutions of ODEs using differential inequalities (Q367169) (← links)
• Bifurcation analysis of a delayed mathematical model for tumor growth (Q502046) (← links)
• Cost-effectiveness analysis of optimal strategy for tumor treatment (Q508264) (← links)
• Mathematical models for immunology: current state of the art and future research directions (Q518216) (← links)
• Maximization of viability time in a mathematical model of cancer therapy (Q680444) (← links)
• Evolutionary game based control for biological systems with applications in drug delivery (Q745060) (← links)
• Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer (Q827694) (← links)
• Optimal control for predicting customized drug dosage for superovulation stage of \textit{in vitro} fertilization (Q890695) (← links)
• Effect of awareness programs and travel-blocking operations in the control of HIV/AIDS outbreaks: a multi-domains SIR model (Q1625717) (← links)
• A time delay model of tumour-immune system interactions: global dynamics, parameter estimation, sensitivity analysis (Q1646154) (← links)
• Global stability analysis and optimal control therapy of blood cell production process (hematopoiesis) in acute myeloid leukemia (Q1712819) (← links)
• Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer (Q1712868) (← links)
• Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine (Q1713207) (← links)
• Bounding the dynamics of a chaotic-cancer mathematical model (Q1721728) (← links)
• The combined effects of optimal control in cancer remission (Q1732198) (← links)
• Optimal control of acute myeloid leukaemia (Q1739304) (← links)
• Controlling IL-7 injections in HIV-infected patients (Q1990146) (← links)
• Spatial avascular growth of tumor in a homogeneous environment (Q2013437) (← links)
• PDE modeling of bladder cancer treatment using BCG immunotherapy (Q2097382) (← links)
• Bacillus Calmette Guerin (BCG) immunotherapy for bladder cancer: a control and mathematical analysis (Q2114503) (← links)
• Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response (Q2115998) (← links)
• Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach (Q2120664) (← links)
• Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach (Q2131714) (← links)
• Investigating of an immune system-cancer mathematical model with Mittag-Leffler kernel (Q2132893) (← links)
• Optimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapy (Q2157844) (← links)
• T cell therapy against cancer: a predictive diffuse-interface mathematical model informed by pre-clinical studies (Q2159016) (← links)
• Dynamics of fractional-order delay differential model for tumor-immune system (Q2185160) (← links)
• Metaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparison (Q2192671) (← links)
• Optimal CAR T-cell immunotherapy strategies for a leukemia treatment model (Q2223666) (← links)
• Modeling the effect of immunotherapies on human castration-resistant prostate cancer (Q2225975) (← links)
• Modelling pulsed immunotherapy of tumour-immune interaction (Q2228589) (← links)
• Personalized medicine for in vitro fertilization procedure using modeling and optimal control (Q2291025) (← links)
• Equilibria and control of metabolic networks with enhancers and inhibitors (Q2305096) (← links)
• Practically scheduling hormone therapy for prostate cancer using a mathematical model (Q2317045) (← links)
• Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control (Q2335463) (← links)
• An agent-based modeling framework linking inflammation and cancer using evolutionary principles: description of a generative hierarchy for the hallmarks of cancer and developing a bridge between mechanism and epidemiological data (Q2341844) (← links)
• A mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer (Q2413866) (← links)
• A nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneity (Q2415802) (← links)
• Modeling pancreatic cancer dynamics with immunotherapy (Q2417545) (← links)
• Stability analysis of a mathematical model for glioma-immune interaction under optimal therapy (Q2422280) (← links)
• Determination of the optimal therapeutic protocols in cancer immunotherapy (Q2455540) (← links)
• Implementation of fractional optimal control problems in real-world applications (Q2660641) (← links)
• Data-driven optimal control of a SEIR model for COVID-19 (Q2699507) (← links)
• Analysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal control (Q3300901) (← links)
• A mathematical model of tumour growth with Beddington–DeAngelis functional response: a case of cancer without disease (Q3300932) (← links)
• TREATMENT OF BLADDER CANCER USING BCG IMMUNOTHERAPY: PDE MODELING (Q3389072) (← links)
• THE EFFECT OF LENVATINIB AND PEMBROLIZUMAB ON THYROID CANCER REFRACTORY TO IODINE 131I SIMULATED BY MATHEMATICAL MODELING (Q5080062) (← links)